Results 21 to 30 of about 318,139 (404)

Occipital Nerve Stimulation in Chronic Migraine: The Relationship Between Perceived Sensory Quality, Perceived Sensory Location, and Clinical Efficacy—A Prospective, Observational, Non-Interventional Study

open access: yesPain and Therapy, 2020
Introduction Occipital nerve stimulation (ONS) is used to treat therapy-resistant chronic migraine. Clinical use has resulted in a wide intraindividual and interindividual variation of clinical efficacy.
Carl H. Göbel   +8 more
doaj   +1 more source

Regular Practice of Autogenic Training Reduces Migraine Frequency and Is Associated With Brain Activity Changes in Response to Fearful Visual Stimuli

open access: yesFrontiers in Behavioral Neuroscience, 2022
Several factors can contribute to the development and chronification of migraines, including stress, which is undoubtedly a major trigger. Beyond pharmacotherapy, other treatment methods also exist, including behavioral techniques aiming at reducing ...
Dóra Dobos   +20 more
doaj   +1 more source

The Migraine Stigma Kaleidoscope View

open access: yesNeurology and Therapy, 2023
The stigma of migraine, despite an impressive body of data on the epidemiological of migraine and the associated disability, burden and cost of migraine to patients, has not been fully evaluated as an important factor in the chronicization of the disease
Elena Gross   +2 more
doaj   +1 more source

Atogepant for the Preventive Treatment of Migraine.

open access: yesNew England Journal of Medicine, 2021
BACKGROUND Atogepant is an oral, small-molecule, calcitonin gene-related peptide receptor antagonist that is being investigated for the preventive treatment of migraine. METHODS In a phase 3, double-blind trial, we randomly assigned adults with 4 to 14
J. Ailani   +7 more
semanticscholar   +1 more source

Stroke and migraine is there a possible comorbidity? [PDF]

open access: yes, 2016
The association between migraine and stroke is still a dilemma for neurologists. Migraine is associated with an increased stroke risk and it is considered an independent risk factor for ischaemic stroke in a particular subgroup of patients.
Del Balzo, Francesca   +7 more
core   +2 more sources

Depressive symptoms are correlated with periaqueductal gray matter functional connectivity in migraine

open access: yesEuropean Psychiatry, 2022
Introduction Depression is the most common comorbidity of migraine. The brain of migraineurs with depression shows differences compared to migraine only or depression only patients.
K. Gecse   +8 more
doaj   +1 more source

Ophthalmoplegic Migraine: Migrainous or Inflammatory? [PDF]

open access: yesCephalalgia, 2004
Contains fulltext : 58890.pdf (Publisher’s version ) (Open Access)
Dussen, D.H. van der   +3 more
openaire   +3 more sources

Real-life use of onabotulinumtoxinA reduces healthcare resource utilization in individuals with chronic migraine: the REPOSE study

open access: yesThe Journal of Headache and Pain, 2021
Background Chronic migraine (CM) is associated with substantial economic burden. Real-world data suggests that onabotulinumtoxinA treatment for CM reduces healthcare resource utilisation (HRU) and related costs.
Katja Kollewe   +3 more
doaj   +1 more source

Favorable outcome of early treatment of new onset child and adolescent migraine-implications for disease modification. [PDF]

open access: yes, 2009
There is evidence that the prevalence of migraine in children and adolescents may be increasing. Current theories of migraine pathophysiology in adults suggest activation of central cortical and brainstem pathways in conjunction with the peripheral ...
A Ferrari   +52 more
core   +1 more source

Familial aggregation of migraine and depression: Insights from a large Australian twin sample [PDF]

open access: yes, 2016
Free to read\ud \ud Objectives: This research examined the familial aggregation of migraine, depression, and their co-occurrence.\ud \ud Methods: Diagnoses of migraine and depression were determined in a sample of 5,319 Australian twins.
Heath, Andrew C   +5 more
core   +3 more sources

Home - About - Disclaimer - Privacy